A Connecticut jury on Friday handed Boehringer Ingelheim Pharmaceuticals its first loss in several bellwether trials in a consolidated proceeding over the alleged bleeding risk of its blood thinner Pradaxa, finding the drug caused a man's internal bleeding and awarding him over $500,000 plus punitive damages.
Engineers, truckers and researchers say they're supportive and cautiously optimistic of U.S. regulators potentially allowing General Motors and a Silicon Valley robotics company to roll out autonomous vehicle-testing programs without certain standard auto safety features.
BMW is facing a proposed class action in New Jersey federal court alleging a newer version of its N63 model automobile engines has the same oil-guzzling defect that resulted in a class action settlement earlier this month.
The federal government and a Houston drug manufacturer and distributor reached an agreement that requires Pharm D Solutions LLC to recall some drugs and stop making new ones until it hires an outside expert to conduct a detailed audit of its facilities that prosecutors allege were unsanitary, they said Monday.
A former New Jersey Devils hockey player has lost his suit against the team alleging it concealed the risk of head injuries from him after a federal judge dismissed the complaint on the grounds he never served the team with the suit.
A California judge turned down Johnson & Johnson and Colgate-Palmolive's bid for a mistrial Monday in a lawsuit over claims asbestos in their talcum baby powder products caused a dying woman’s cancer, rejecting their arguments that he unfairly questioned their witnesses and allowed in biased evidence on ovarian cancer.
The federal government on Friday told the Ninth Circuit that Oakland's and San Francisco's suits seeking to hold Big Oil liable for climate change-related infrastructure damage are preempted by the Clean Air Act and trample over constitutionally enshrined foreign policy authority.
A French unit of General Electric Co. has appealed to the Eleventh Circuit, following an Alabama district judge's decision to adopt a recommendation that a $45 million dispute over allegedly faulty motors be returned to state court.
The U.S. Supreme Court on Monday said a judge, not a jury, must decide if the U.S. Food and Drug Administration would have rejected a proposed warning of the risks associated with Merck's osteoporosis drug Fosamax, resolving a question over whether a judge or jury should interpret ambiguities in FDA labeling rules.
The D.C. federal judge presiding over public interest groups' challenge to President Donald Trump's executive order requiring that for every new regulation, two rules must be eliminated, said Friday that federal agencies must do a better job complying with discovery.
CVS Health Corp. can escape a putative class action over claims it falsely advertised its line of CVS Health Glucosamine products, a California federal judge has ruled, finding that the pharmacy giant's packaging complies with federal labeling law, preempting the state law claims asserted in the suit.
BMW AG’s chief executive on Thursday blasted a European Union investigation alleging that it colluded with other German car makers to keep new emissions technology off the market for several years, calling the claims unfounded.
Attorneys for General Motors vehicle owners with allegedly defective transmissions opened a proposed nationwide federal class damages suit in Delaware Friday, becoming at least the third prospective multistate class challenge to the automaker’s gearboxes.
Crowell & Moring LLP partner Cheryl Falvey, a former general counsel for the U.S. Consumer Product Safety Commission, spoke to Law360 about what she's watching these days on the product liability front, including the thorny issues cropping up around the "internet of things."
The nation's largest utility company, Pacific Gas and Electric, has paid at least $89 million in the past year in legal fees to firms directly involved with its bankruptcy, civil, criminal and regulatory cases stemming from California wildfires — and the vast majority of that sum has gone to Cravath Swaine & Moore LLP.
A Philadelphia jury returned $80 million in damages against a Johnson & Johnson unit on Friday in the latest trial over chronic pain and other complications caused by its pelvic mesh implants.
Dorsey & Whitney LLP has given its product liability practice a boost, bringing on a veteran litigator from Goodell DeVries as a partner in its New York office.
The Eleventh Circuit has backed a lower court decision favoring Royal Caribbean Cruises Ltd.'s argument that it is not responsible for a passenger's injury when part of a lighting machine fell on her head while she was on a dance floor, saying she can't show the cruise company is at fault.
Popular light-up children's shoes made by Skechers USA Inc. contain a dangerous defect that can cause skin burns, an Illinois mother claimed in a proposed class action filed Thursday.
Two Ninth Circuit judges on Thursday criticized the U.S. Environmental Protection Agency's process for approving Dow AgroSciences LLC's glyphosate weedkiller Enlist Duo, saying the EPA's voluntary offer to reconsider its approval of the weedkiller has resulted in it skirting legal challenges altogether.
The IRS, which enforces anti-trafficking tax laws against state-regulated cannabis businesses, should be fair and apply the same policy against pharmaceutical companies that illegally market their opioids, says Kat Allen at Wykowski Law.
On May 13, a California jury returned a $2 billion verdict against Monsanto in the third trial over allegations that its popular weedkiller Roundup causes cancer. The Roundup trials highlight the importance of issues including punitive damages, celebrity influence and the value of jury exercises, say attorneys at Wiley Rein.
In this monthly series, legal recruiting experts from Major Lindsey & Africa interview legal industry leaders about the increasingly competitive business environment. Here, Rod Osborne talks with Gary Tully, head of legal operations at Gilead Sciences.
The U.S. Food and Drug Administration's multipronged approach to assessing whether cannabidiol, commonly known as CBD, can be safely introduced into consumable products charts a path toward much-needed clarity, but the agency's upcoming hearing on the topic is unlikely to provide concrete guidance, say attorneys at Eversheds Sutherland.
My mother's connection to her Native American heritage had a major influence on my career — my decision to enter the legal profession was driven by the desire to return to my tribal community and help it in any way I could, says Jason Hauter of Akin Gump.
Lawsuits involving property damage due to fire often require the retention of an expert to investigate the fire, but testimony can be excluded if the expert lacks the required licenses. Attorneys at Tucker Ellis break down the different licensing requirements for fire scene inspection in all 50 states.
Retired U.S. Supreme Court Justice John Paul Stevens' new book, "The Making of a Justice," is required reading for anyone interested in 20th and 21st century America, says Seventh Circuit Chief Judge Diane Wood.
In Air and Liquid Systems v. DeVries, the U.S. Supreme Court recently cast doubt on the "bare metal" defense against manufacturer liability in a maritime tort context. But both the majority and dissenting opinions provide a road map to using this defense in other situations, say John Vales and Stephen Turner of Dentons.
If a client does not demand the application of project management techniques at the start of a matter, or a law firm does not routinely apply them, it is highly likely that additional, avoidable work — legal project management debt — will materialize throughout the matter, says Anthony Widdop of Shearman & Sterling.
Science suggests that at least some jurors pay attention to less than 65% of the evidence during a trial due to "task-unrelated thoughts," but there are steps attorneys can take to present information in a more engaging, cognition-friendly fashion, say Dennis Stolle and Dennis Devine of Barnes & Thornburg.